Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2019

Sep 17, 2019

30870_dirs_2019-09-17_f58f6012-607d-4db6-ac86-f431ea3d7c2b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2019-09-16

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-16 Common Stock S 6000 $12.7449 Disposed 244022 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.